New combo therapy aims to fight aggressive lung cancer

NCT ID NCT07226999

Recruiting now Disease control Sponsor: Pfizer Source: ClinicalTrials.gov ↗

First seen Nov 12, 2025 · Last updated Apr 30, 2026 · Updated 24 times

Summary

This study tests a new medicine called PF-08634404 combined with chemotherapy for adults with extensive-stage small cell lung cancer, a fast-growing cancer that has spread. About 550 people who haven't had prior treatment for this stage will join. The goal is to see if the new combo works better than current standard treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

BRCR Coral Springs
RECRUITING

Coral Springs, Florida, 33065, United States
BRCR Global - Coral Springs
RECRUITING

Coral Springs, Florida, 33065, United States
BRCR Global - Tamarac
RECRUITING

Tamarac, Florida, 33321, United States
Border Medical Oncology Research Unit
NOT_YET_RECRUITING

Albury, New South Wales, 2640, Australia
Clario
NOT_YET_RECRUITING

Philadelphia, Pennsylvania, 19103, United States
Doctor's Center Hematology & Oncology Group
RECRUITING

Manati, 00674, Puerto Rico
Highlands Oncology Group
RECRUITING

Fayetteville, Arkansas, 72703, United States
Highlands Oncology Group
RECRUITING

Rogers, Arkansas, 72758, United States
Highlands Oncology Group
RECRUITING

Springdale, Arkansas, 72762, United States
Hospital Oncologico Dr. Isaac Gonzalez-Martinez
RECRUITING

San Juan, 00935, Puerto Rico
Hospital Universitario 12 de Octubre
NOT_YET_RECRUITING

Madrid, Madrid, Comunidad de, 28041, Spain
Hôpital Ambroise Paré
NOT_YET_RECRUITING

Boulogne-Billancourt, Île-de-France Region, 92100, France
Kansai Medical University Hospital
RECRUITING

Hirakata, Osaka, 573-1191, Japan
Mid Florida Hematology and Oncology Center
RECRUITING

Orange City, Florida, 32763, United States
National Cheng Kung University Hospital
NOT_YET_RECRUITING

Tainan, 704302, Taiwan
National Taiwan University Hospital
NOT_YET_RECRUITING

Taipei, 10002, Taiwan
Pan American Center for Oncology Trials, LLC
RECRUITING

San Juan, 00909, Puerto Rico
Pan American Center for Oncology Trials, LLC - Mayaguez Office Mayaguez Medical Center
RECRUITING

Mayagüez, 00680, Puerto Rico
Shizuoka Cancer Center
RECRUITING

Nagaizumi-cho, Shizuoka, 411-8777, Japan
Taipei Medical University Hospital
RECRUITING

Taipei, 110, Taiwan
Texas Oncology - Gulf Coast
RECRUITING

Beaumont, Texas, 77702, United States
Texas Oncology - Gulf Coast
RECRUITING

Houston, Texas, 77024, United States
Texas Oncology - Gulf Coast
RECRUITING

Houston, Texas, 77054, United States
Texas Oncology - Gulf Coast
RECRUITING

Pearland, Texas, 77584, United States
Texas Oncology - Gulf Coast
RECRUITING

Sugar Land, Texas, 77479, United States
Texas Oncology - Gulf Coast
RECRUITING

The Woodlands, Texas, 77380, United States
Texas Oncology - Gulf Coast
RECRUITING

Webster, Texas, 77598, United States
Texas Oncology - San Antonio
RECRUITING

Fredericksburg, Texas, 78624, United States
Texas Oncology - San Antonio
RECRUITING

New Braunfels, Texas, 78130, United States
Texas Oncology - San Antonio
RECRUITING

San Antonio, Texas, 78217, United States
Texas Oncology - San Antonio
RECRUITING

San Antonio, Texas, 78240, United States
Texas Oncology - San Antonio
RECRUITING

San Antonio, Texas, 78258, United States

Conditions

Explore the condition pages connected to this study.

SMALL CELL LUNG CANCER (SCLC) SMALL CELL LUNG CANCER, SCLC